Myeloma nutritional expert, Danny Parker, has been following curcumin research for years. He emailed me last evening, excited about a new micro study he found:
This study was just published on February 18th in the Journal of Hematological Malignancies, tracking two patients with smoldering myeloma. Margaret Graziano surfaced it on her blog recently (http://margaret.healthblogs.org/), so thanks to her we have more information on this potentially important development.
EDITOR’S NOTE: Click-on the Full Text PDF link to access the entire report. Use the link below or the one located on the lower left side of the abstract page in red.
Summary findings are encouraging:
“Both patients showed continued improvement in a number of markers of disease activity including serum free light chains, paraprotein and % plasma cells in the bone marrow. These results suggest that patients with smoldering myeloma may benefit from daily ingestion of curcumin and long term use does not result in toxicity.”
I would suggest that this result not only portends well for smoldering myeloma, but also, in particular, for patients with minimal residual disease.
If you are excited, we’re excited, Danny! Here are links to several of Danny’s columns about this mysterious compound–the only known supplement to have proven anti-myeloma properties. And using it enhances how well Velcade and Revlimid works, too!
Thanks for the update, Danny! The ongoing challenge is to somehow get enough curcumin into our bloodstreams and keep in there. Topic for a future column?
Feel good and keep smiling! Pat